Works matching DE "ONCOGENES"
Results: 5000
Surgery for Breast Cancer Is Not Obsolete.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 928
- By:
- Publication type:
- Article
Local Therapy for Breast Cancer in the Molecular Era: Relevant or Relic?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 918
- By:
- Publication type:
- Article
Tumor Heterogeneity: The Lernaean Hydra of Oncology?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 781
- By:
- Publication type:
- Article
Heterogeneity and Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 772
- By:
- Publication type:
- Article
The Current Clinical Value of the DCIS Score.
- Published in:
- Oncology (08909091), 2014, p. 1
- By:
- Publication type:
- Article
HER2-Positive Breast Cancer: The Story Goes On.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 290
- By:
- Publication type:
- Article
HER2-Targeted Therapy for Early-Stage Breast Cancer: A Comprehensive Review.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 281
- By:
- Publication type:
- Article
Pertuzumab: Increasing the Options.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 3, p. 199
- By:
- Publication type:
- Article
Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 3, p. 186
- By:
- Publication type:
- Article
Personalized Medicine and Anti-EGFR Antibody Therapy in the Treatment of Metastatic Colorectal Cancer: KRAS and Beyond.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 96
- By:
- Publication type:
- Article
TCGA's Breast Cancer Project May Yield Important Therapeutic Benefits, but It's Too Early to Be Sure.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 12, p. 1280
- By:
- Publication type:
- Article
The Cancer Genome Atlas: Clinical Applications for Breast Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 12, p. 1263
- By:
- Publication type:
- Article
Squamous Cell Lung Cancer: Where Do We Stand and Where Are We Going?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 9, p. 914
- By:
- Publication type:
- Article
Do Oncogenic Drivers Exist in Squamous Cell Carcinoma of the Lung?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 9, p. 906
- By:
- Publication type:
- Article
Clinical Applications of The Cancer Genome Atlas Project (TCGA) for Squamous Cell Lung Carcinoma.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 9, p. 899
- By:
- Publication type:
- Article
Use of Molecular Biomarkers to Inform Adjuvant Therapy for Colon Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 8, p. 746
- By:
- Publication type:
- Article
"Missing the Target" in Urothelial Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 3, p. 227
- By:
- Publication type:
- Article
Advanced Urothelial Carcinoma: Moving the Field Forward.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 3, p. 233
- By:
- Publication type:
- Article
Targeted Therapy in Advanced Urothelial Carcinoma.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 3, p. 219
- By:
- Publication type:
- Article
Fifteen Years of Anti-HER2 Therapy.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 3, p. 151
- By:
- Publication type:
- Article
For Breast Cancer Patients With Brain Mets, New Drug Combo May Be Option.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 12, p. 1209
- Publication type:
- Article
ASCO REPORTS: HIGHLIGHTS FROM EXCLUSIVE ONCOLOGY INTERVIEWS.
- Published in:
- 2012
- Publication type:
- Interview
Tumor Biology Trumps Anatomy in Breast Cancer Brain Metastases.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 7, p. 666
- By:
- Publication type:
- Article
Brain Metastasis in Breast Cancer: Last Barrier to the Cure?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 7, p. 664
- By:
- Publication type:
- Article
New Insights and Emerging Therapies for Breast Cancer Brain Metastases.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 7, p. 652
- By:
- Publication type:
- Article
Improving Therapy for HER2- Positive Cancers Through Neoadjuvant Studies.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 1, p. 34
- By:
- Publication type:
- Article
Neoadjuvant Therapy for HER2-Positive Early-Stage Breast Cancer: The Future Is Almost Here.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 1, p. 26
- By:
- Publication type:
- Article
What Is the Current Standard of Care for Anti-HER2 Neoadjuvant Therapy in Breast Cancer?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 1, p. 20
- By:
- Publication type:
- Article
Select Interviews From the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting.
- Published in:
- 2011
- Publication type:
- Interview
Dramatic CLEOPATRA Findings Support Addition of Pertuzumab to Regimen for HER2-Positive Metastatic Breast Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 14, p. 1416
- Publication type:
- Article
ASCO REPORTS: HIGHLIGHTS FROM EXCLUSIVE ONCOLOGY INTERVIEWS.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 8, p. 748
- Publication type:
- Article
HER2-Targeted Therapies: How Far We've Come--and Where We're Headed.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 5, p. 425
- By:
- Publication type:
- Article
Chronic Inflammation and Cancer: The Role of the Mitochondria.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 5, p. 400
- By:
- Publication type:
- Article
Inflammatory Breast Cancer: What Progress Have We Made?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 3, p. 264
- By:
- Publication type:
- Article
Anthracyclines Are a Critical Component of Adjuvant Chemotherapy Regimens for High-Risk Early Breast Cancer.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 134
- By:
- Publication type:
- Article
Can We Abandon Anthracyclines for Early Breast Cancer Patients?
- Published in:
- Oncology (08909091), 2011, v. 25, n. 2, p. 115
- By:
- Publication type:
- Article
Myth Busting: Does Real-World Experience Lead to Better Drug Choices?
- Published in:
- Oncology (08909091), 2010, v. 24, n. 14, p. 1272
- By:
- Publication type:
- Article
Inflammatory Breast Cancer: A Complex Disease.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 14, p. 1561
- By:
- Publication type:
- Article
Molecular Determinants of the Inflammatory Breast Cancer Phenotype.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 14, p. 1556
- By:
- Publication type:
- Article
Adult Burkitt Lymphoma Advances in Diagnosis and Treatment.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 13, p. 1508
- By:
- Publication type:
- Article
Adult Burkitt Lymphoma: Too Soon to Declare Victory.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 13, p. 1518
- By:
- Publication type:
- Article
Travel Grant Recipients.
- Published in:
- 2007
- Publication type:
- Abstract
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation.
- Published in:
- Nature Structural & Molecular Biology, 2012, v. 19, n. 2, p. 220, doi. 10.1038/nsmb.2207
- By:
- Publication type:
- Article
DNA secondary structures and epigenetic determinants of cancer genome evolution.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 8, p. 950, doi. 10.1038/nsmb.2089
- By:
- Publication type:
- Article
The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a.
- Published in:
- Nature Structural & Molecular Biology, 2007, v. 14, n. 7, p. 591, doi. 10.1038/nsmb1250
- By:
- Publication type:
- Article
Splicing oncogenes.
- Published in:
- Nature Structural & Molecular Biology, 2007, v. 14, n. 3, p. 174, doi. 10.1038/nsmb0307-174
- By:
- Publication type:
- Article
An Achilles' heel for breast cancer?
- Published in:
- Nature Structural & Molecular Biology, 2005, v. 12, n. 5, p. 387, doi. 10.1038/nsmb0505-387
- By:
- Publication type:
- Article
E3 ligase activity and suppression of breast cancer.
- Published in:
- Nature Structural & Molecular Biology, 2004, v. 11, n. 1, p. 8, doi. 10.1038/nsmb0104-8
- By:
- Publication type:
- Article
PARP inhibitors: What urologists need to know.
- Published in:
- 2021
- By:
- Publication type:
- Interview
AR-V7 shows interaction with prostate Ca therapy: Biomarker linked with improved OS in men with metastatic castration-resistant PCa on taxanes.
- Published in:
- Urology Times, 2018, v. 46, n. 6, p. 6
- By:
- Publication type:
- Article